IP Verse

In Re: Aflibercept Patent Litigation - 1:24-md-03103

Explore the details of the In Re: Aflibercept Patent Litigation case under case number 1:24-md-03103 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-md-03103
Filing Date
Apr 11, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Celltrion, Inc. -
BIOCON BIOLOGICS INC. -
Samsung Bioepis, CO., LTD., -
AMGEN USA, INC. -
Amgen, Inc. -
Amgen Inc. -
Regeneron Pharmaceuticals, Inc. -
AFLIBERCEPT PATENT LITIGATION -
Mylan Pharmaceuticals Inc. -
Formycon AG -
Sandoz Inc. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 16, 2025NOTICE by Sandoz Inc. Defendants' Notice of Deposition of Dr. Bernhardt Trout Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/16/2025)PACER Document
Jul 16, 2025NOTICE by Sandoz Inc. Defendants' Notice of Deposition of Kevin Clark Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/16/2025)PACER Document
Jul 16, 2025NOTICE by Sandoz Inc. Defendants' Notice of Deposition of Dr. Sean Sheridan Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Wakefield, Jeffrey) (Entered: 07/16/2025)PACER Document
Jul 17, 2025JPML CONDITIONAL TRANSFER ORDER FINALIZED (CTO-2) - 1 action(s) re: pldg. (1 in CAC/2:25-cv-05499, 50 in MDL No. 3103) Inasmuch as no objection is pending at this time, the stay is lifted. Signed by Clerk of the Panel James V. Ingold on 7/17/2025. Associated Cases: MDL No. 3103, CAC/2:25-cv-05499. (snc) (Entered: 07/17/2025)PACER Document
Jul 24, 2025Joint MOTION to Reschedule Preliminary Injunction Hearing by Regeneron Pharmaceuticals, Inc.. Associated Cases: 1:24-md-03103-TSK-JPM, 1:24-cv-00085-TSK(Pogue, David) (Entered: 07/24/2025)PACER Document
Jul 25, 2025Request for Hearing on its Motion to Dissolve the Preliminary Injunction filed by Formycon AG. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) Modified to make pending motion on 7/28/2025 (dk). (Entered: 07/25/2025)PACER Document
Jul 25, 2025MOTION for Leave to File Under Seal its Reply Memorandum in Support of its Motion to Dissolve the Preliminary Injunction by Formycon AG. (Attachments: # 1 Defendant Formycon AG's Memorandum in Support of Motion for Leave to File Under Seal)Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM(Griffith, M.) (Entered: 07/25/2025)PACER Document
Jul 28, 2025ORDER GRANTING MOTION FOR LEAVE TO FILE UNDER SEAL (ECF NO. 579 ). Signed by Chief District Judge Thomas S. Kleeh on 07/28/2025. Associated Cases: 1:24-md-03103-TSK-JPM, 1:23-cv-00097-TSK-JPM (snc) (Entered: 07/28/2025)PACER Document
Jul 31, 2025MEMBER CASE OPENED: Case Transferred into the Northern District of West Virginia: District of California Central, 2:25-cv-05499, REGENERON PHARMACEUTICALS, INC. v. AMGEN INC. as NDWV case 1:25-cv-74 pursuant to 577 CONDITIONAL TRANSFER ORDER FINALIZED (CTO-1) and filed the 24 Pretrial Order #1: INITIAL SCHEDULING CONFERENCE. (snc) (Entered: 07/31/2025)PACER Document